Early detection and intervention strategy for type 2 diabetes mellitus (T2DM) may lessen the global health and financial burden that this condition imposes. Researchers have now demonstrated that blood-based DNA methylation scores can predict 10-year T2DM incidence risk. DNA methylation ratings were created and validated in two European cohorts. Data were collected from 14,613 volunteers who participated in the Generation Scotland study.
To confirm if the findings can be replicated in individuals from various backgrounds, the team also conducted the analyses on 1,451 participants from a study with a basis in Germany. The researchers discovered that a more precise prediction was made when DNA methylation information was combined with the risk variables. These methylation patterns can be used to monitor aging and disease development. The results obtained from the study might prompt…
